Affiliation:
1. Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Xinchuan Road 2222, Chengdu, Sichuan, China
2. School of Medical and Allied Sciences, K.R. Mangalam University, Sohna Road, Gurugram-122103, India
Abstract
Parkinson’s disease is one of the most common adult-onset, a chronic disorder involving
neurodegeneration, which progressively leads to deprivation of dopaminergic neurons in substantia
nigra, causing a subsequent reduction of dopamine levels in the striatum resulting in tremor, myotonia,
and dyskinesia. Genetics and environmental factors are believed to be responsible for the onset
of Parkinson’s disease. The exact pathogenesis of Parkinson's disease is quite complicated and the
present anti-Parkinson's disease treatments appear to be clinically insufficient. Comprehensive researches
have demonstrated the use of natural products such as ginseng, curcumin, ashwagandha,
baicalein, etc. for the symptomatic treatment of this disease. The neuroprotective effects exhibited
by these natural products are mainly due to their ability to increase dopamine levels in the striatum,
manage oxidative stress, mitochondrial dysfunction, glutathione levels, clear the aggregation of α-
synuclein, induce autophagy and decrease the pro-inflammatory cytokines and lipid peroxidation.
This paper reviews various natural product studies conducted by scientists to establish the role of
natural products (both metabolite extracts as well as pure metabolites) as adjunctive neuroprotective
agents.
Funder
National Natural Science Foundation of China
National Key Research and Development Program of China
Publisher
Bentham Science Publishers Ltd.
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献